CN114617262A - Preparation method of flavor enzyme enzymolysis nanoparticles for resisting gastrointestinal digestion - Google Patents
Preparation method of flavor enzyme enzymolysis nanoparticles for resisting gastrointestinal digestion Download PDFInfo
- Publication number
- CN114617262A CN114617262A CN202210380054.XA CN202210380054A CN114617262A CN 114617262 A CN114617262 A CN 114617262A CN 202210380054 A CN202210380054 A CN 202210380054A CN 114617262 A CN114617262 A CN 114617262A
- Authority
- CN
- China
- Prior art keywords
- nanoparticles
- enzymolysis
- preparing
- flavourzyme
- steps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 52
- 230000029087 digestion Effects 0.000 title claims abstract description 43
- 230000002496 gastric effect Effects 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 102000004190 Enzymes Human genes 0.000 title claims description 29
- 108090000790 Enzymes Proteins 0.000 title claims description 29
- 239000000796 flavoring agent Substances 0.000 title claims description 11
- 235000019634 flavors Nutrition 0.000 title claims description 11
- 108010007119 flavourzyme Proteins 0.000 claims abstract description 36
- 239000002245 particle Substances 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 18
- 238000002156 mixing Methods 0.000 claims abstract description 13
- 239000012074 organic phase Substances 0.000 claims abstract description 11
- 239000012071 phase Substances 0.000 claims abstract description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 84
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 70
- 235000013734 beta-carotene Nutrition 0.000 claims description 70
- 239000011648 beta-carotene Substances 0.000 claims description 70
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 70
- 229960002747 betacarotene Drugs 0.000 claims description 70
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 70
- 239000000243 solution Substances 0.000 claims description 64
- 239000012460 protein solution Substances 0.000 claims description 48
- 238000010438 heat treatment Methods 0.000 claims description 38
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 31
- 235000015097 nutrients Nutrition 0.000 claims description 25
- 108010073771 Soybean Proteins Proteins 0.000 claims description 19
- 239000008187 granular material Substances 0.000 claims description 18
- 238000007664 blowing Methods 0.000 claims description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 235000018102 proteins Nutrition 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 235000019710 soybean protein Nutrition 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 6
- 239000000413 hydrolysate Substances 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 235000012754 curcumin Nutrition 0.000 claims description 3
- 239000004148 curcumin Substances 0.000 claims description 3
- 229940109262 curcumin Drugs 0.000 claims description 3
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 239000001656 lutein Substances 0.000 claims description 3
- 235000012680 lutein Nutrition 0.000 claims description 3
- 229960005375 lutein Drugs 0.000 claims description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 3
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 3
- 238000001338 self-assembly Methods 0.000 claims description 3
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 3
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 2
- 244000105624 Arachis hypogaea Species 0.000 claims description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 2
- 235000018262 Arachis monticola Nutrition 0.000 claims description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- 102000004407 Lactalbumin Human genes 0.000 claims description 2
- 108090000942 Lactalbumin Proteins 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 2
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 229940098773 bovine serum albumin Drugs 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 235000020232 peanut Nutrition 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 235000021283 resveratrol Nutrition 0.000 claims description 2
- 229940016667 resveratrol Drugs 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 235000021241 α-lactalbumin Nutrition 0.000 claims description 2
- 229920002494 Zein Polymers 0.000 claims 1
- 229960001701 chloroform Drugs 0.000 claims 1
- 239000005019 zein Substances 0.000 claims 1
- 229940093612 zein Drugs 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 238000010924 continuous production Methods 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 abstract 4
- 239000011787 zinc oxide Substances 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 24
- 229940088598 enzyme Drugs 0.000 description 24
- 150000001413 amino acids Chemical class 0.000 description 16
- 238000005303 weighing Methods 0.000 description 13
- 238000001816 cooling Methods 0.000 description 12
- 238000005538 encapsulation Methods 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 239000000969 carrier Substances 0.000 description 7
- 230000002209 hydrophobic effect Effects 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 108091005658 Basic proteases Proteins 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 101710118538 Protease Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002983 circular dichroism Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 102000034238 globular proteins Human genes 0.000 description 1
- 108091005896 globular proteins Proteins 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000002539 nanocarrier Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
- A23J3/16—Vegetable proteins from soybean
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/346—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/045—Organic compounds containing nitrogen as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion, which comprises the following steps: preparing particles, preparing an organic phase, mixing the two phases, removing the organic phase and removing a small amount of insoluble substances. The zinc oxide has good shape and structure, good chemical zinc oxide, good anti-digestion performance, protection of fat-soluble cellulose from being damaged during digestion in vivo, contribution to absorption by human body, simple raw materials, low cost, simple and easily-controlled preparation process, economic use, greenness, safety and suitability for industrial continuous production.
Description
Technical Field
The invention belongs to the technical field of food additives, and particularly relates to a preparation method of flavor enzyme enzymolysis nanoparticles for resisting gastrointestinal digestion.
Background
Fat-soluble nutrients have low solubility in water and poor permeability to gastrointestinal mucus, and are difficult to pass through a water layer without agitation, and thus are difficult to absorb and utilize in the human body. In order to improve the bioavailability of the fat-soluble nutrient, the fat-soluble nutrient is prevented from being damaged and degraded in the digestive tract to the maximum extent, so that the fat-soluble nutrient can smoothly reach epithelial cells of small intestines to exert the health-care effect. If a carrier form is adopted to embed the fat-soluble nutrient, the solubility of the nutrient in water is greatly enhanced, and the utilization efficiency of the nutrient can be greatly improved.
Protein is a biological material with great potential value, but the protein molecule is highly compressed and has compact structure, hydrophobic active substances are difficult to wrap in the protein molecule, and the controlled release performance of the loaded fat-soluble functional components is poor. Thereby limiting their use in the field of functional carriers.
After the protein is hydrolyzed by protease, the polypeptide formed by hydrolysis has good interfacial activity and self-assembly capability, and new carriers such as nano-micelle, nano-fiber, nano-tube, nano-particle and the like are formed in a non-covalent combination mode to wrap hydrophobic active substances, so that the protein has great potential in the delivery of nutritional food and drugs. Meanwhile, the number of enzyme cutting sites of the nano-particles formed by enzymolysis in the gastrointestinal digestion process is reduced compared with that of original protein, so that the complete morphological structure of the nano-particles can be maintained more easily in the digestion process, fat-soluble nutrient substances wrapped in the nano-particles can be better protected, and the absorption and utilization of a human body are facilitated.
CN202110683000.6 adopts the combined action of electrostatic crosslinking and enzymolysis of sulfite to prepare nanoparticles, and sulfite or bisulfite is decomposed when meeting strong acid, so that the prepared particles can change along with the change of pH, thereby reducing the stability of the particles in the process of gastric digestion and failing to well protect the wrapped fat-soluble nutrients. CN201810009738.2 adopts an ultrasonic method to wrap curcumin in nanoparticles formed by enzymolysis, and the method is only suitable for some nutrients with weak non-polarity and is not suitable for nutrients with strong non-polarity, such as beta-carotene, vitamin E and the like, thereby limiting the application range of the method.
The flavor protease hydrolyzes hydrophilic groups, so that some hydrophilic amino acids on the surface can be hydrolyzed in the process of preparing the nano particles, the interior hidden in the interior and provided with a compact structure is exposed, the amphipathy of hydrolysate is enhanced, alkaline protease, trypsin, pepsin and the like are commonly used for preparing the enzyme for embedding the fat-soluble nutrient nano particles by an enzymolysis method, and the flavor protease has great application potential in the aspect.
Aiming at the defects of the prior art, the invention hopes to find an efficient and simple method, and the obtained product has small nano particles, good embedding effect, high stability and bioavailability, and effectively solves the adverse effect of gastrointestinal digestion of a human body on fat-soluble nutrients.
Disclosure of Invention
This section is for the purpose of summarizing some aspects of embodiments of the invention and to briefly introduce some preferred embodiments. In this section, as well as in the abstract and the title of the invention of this application, simplifications or omissions may be made to avoid obscuring the purpose of the section, the abstract and the title, and such simplifications or omissions are not intended to limit the scope of the invention.
The present invention has been made keeping in mind the above and/or other problems occurring in the prior art.
Therefore, the invention aims to overcome the defects in the prior art and provide a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion.
In order to solve the technical problems, the invention provides the following technical scheme: a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion comprises the following steps:
preparing particles, namely performing enzymolysis on a protein solution by using flavor enzyme, heating to inactivate the enzyme and simultaneously promoting self-assembly to prepare nano particles;
preparing an organic phase, namely mixing the fat-soluble nutrient with an organic solvent to prepare a fat-soluble nutrient solution;
mixing the two phases: mixing the fat-soluble nutrient solution and the nano particles by using a high-speed stirrer;
removing an organic phase: removing the organic solvent by using a nitrogen blowing instrument;
removing a small amount of insoluble substances, centrifuging the hydrolysate at a rotation speed of 10000r/min for 20 min.
The invention relates to a preferable scheme of a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion, which comprises the following steps: preparing an organic phase, wherein the organic solvent comprises one or more of dichloromethane, methanol, ethyl acetate, chloroform and acetonitrile. .
As a preferable scheme of the preparation method of the gastrointestinal digestion resistant flavourzyme enzymolysis nanoparticle, the preparation method comprises the following steps: in the preparation of the particles, the protein in the protein solution is one or more of soybean protein isolate, alpha-lactalbumin, rice protein, peanut protein isolate, bovine serum albumin, casein and corn protein.
The invention relates to a preferable scheme of a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion, which comprises the following steps: preparing organic phase, wherein the fat-soluble nutrient comprises one of beta-carotene, vitamin-E, lutein, curcumin, resveratrol and vitamin D.
The invention relates to a preferable scheme of a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion, which comprises the following steps: in the two-phase mixing, the fat-soluble nutrient solution and the nano particles are mixed according to the volume ratio of 1: 2-9.
The invention relates to a preferable scheme of a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion, which comprises the following steps: in the preparation of the particles, the concentration of the protein solution is 0.5-2% by weight.
The invention relates to a preferable scheme of a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion, which comprises the following steps: in the preparation of the granules, the ratio of the flavor enzyme to the substrate is 0.05-0.2% by weight.
The invention relates to a preferable scheme of a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion, which comprises the following steps: in the mixing of the two phases, the rotating speed of a high-speed stirrer is 8000rpm, and the stirring time is 4-8 min.
The invention relates to a preferable scheme of a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion, which comprises the following steps: in preparing the granules, the concentration of the protein solution was 2% by weight.
The invention relates to a preferable scheme of a preparation method of flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion, which comprises the following steps: the ratio of flavourzyme to substrate in the granulate was 0.1% by weight.
The invention provides a method for preparing flavor enzyme enzymolysis nano-particles for resisting gastrointestinal digestion, which has the following advantages:
1. the formed nanoparticles have good shape structure: spherical and at the same time uniform. The particle size is 80-100nm, and the particle size is small, so that the particles can smoothly enter epithelial cells of small intestines.
2. The prepared nano-particles have ideal anti-digestibility, so that the fat-soluble vitamins are protected from being damaged during digestion in vivo, and the absorption by a human body is facilitated.
3. Compared with the fat-soluble vitamin micelle dispersion, the water-soluble fat-soluble nutrient nano-particles prepared by the invention have higher chemical stability, and the retention rate of the fat-soluble nutrient is still kept above 50 percent after being placed for 15 days under illumination.
4. The invention has the advantages of simple raw materials, low raw material cost, simple and easily-controlled preparation process, economy, practicality, greenness, safety and suitability for industrial continuous production.
Drawings
In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings needed to be used in the description of the embodiments will be briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings based on these drawings without inventive exercise. Wherein:
FIG. 1 is a flow chart of the preparation of the present invention; .
FIG. 2 is a graph showing the release of beta-carotene during gastric digestion in vitro in example 6 of the present invention and in comparative example 1;
FIG. 3 shows the release of beta-carotene during intestinal digestion in vitro in example 6 and comparative example 1 in accordance with the present invention;
FIG. 4 is a transmission electron micrograph of nanoparticles prepared in example 6;
fig. 5 is a projection electron micrograph of the nanoparticles of comparative example 1.
Detailed Description
In order to make the aforementioned objects, features and advantages of the present invention more comprehensible, embodiments accompanying the present invention are described in detail below with reference to examples.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention, but the present invention may be practiced in other ways than those specifically described and will be readily apparent to those of ordinary skill in the art without departing from the spirit of the present invention, and therefore the present invention is not limited to the specific embodiments disclosed below.
Furthermore, reference herein to "one embodiment" or "an embodiment" means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one implementation of the invention. The appearances of the phrase "in one embodiment" in various places in the specification are not necessarily all referring to the same embodiment, nor are separate or alternative embodiments mutually exclusive of other embodiments.
The nitrogen blowing instrument adopted in the embodiment of the invention is an American organization nitrogen blowing instrument N-EVAP 112 (without gears), and the stirrer used in the invention is a pre-sublimation heat collection type constant temperature heating magnetic stirrer DF-101S.
Example 1
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 2% (w/w) protein solution and 0.1% (w/w) beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 30 minutes, and heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme, wherein the ratio of the enzyme to a substrate is 0.1% (w/w). After cooling to room temperature, dropwise adding the beta-carotene solution into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 4min, and the ratio of the final organic solution to the water solution is 1: 5. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifuge at the rotating speed of 10000r/min for 20 min.
Example 2
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 1% (w/w) protein solution and 0.1% (w/w) beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 30 minutes, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, the beta-carotene solution is dropwise added into the enzymatic hydrolysate after enzyme deactivation under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 4min, and the ratio of the final organic solution to the water solution is 1: 5. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifuge at the rotating speed of 10000r/min for 20 min.
Example 3
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 0.5% (w/w) protein solution and 0.1% (w/w) beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the constant temperature of 50 ℃ for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 30 minutes, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, the beta-carotene solution is dropwise added into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 4min, and the ratio of the final organic solution to the water solution is 1: 5. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifuge at the rotating speed of 10000r/min for 20 min.
Example 4
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 2% (w/w) of protein solution and 0.1% (w/w) of beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 30 inches, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme, wherein the ratio of the enzyme to a substrate is 0.05% (w/w). After cooling to room temperature, the beta-carotene solution is dropwise added into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 4min, and the ratio of the final organic solution to the water solution is 1: 2. Then a nitrogen blowing instrument is used for removing the ethyl acetate,
example 5
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 2% (w/w) of protein solution and 0.1% (w/w) of beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 30 minutes, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, the beta-carotene solution is dropwise added into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 4min, and the ratio of the final organic solution to the water solution is 1: 9. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifuge at the rotating speed of 10000r/min for 20 min.
Example 6
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 2% (w/w) of protein solution and 0.1% (w/w) of beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 60 minutes, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, the beta-carotene solution is dropwise added into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 6min, and the ratio of the final organic solution to the water solution is 1: 5. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifuge at the rotating speed of 10000r/min for 20 min.
Example 7
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing a 2% (w/w) protein solution and a 0.1% (w/w) beta-carotene solution by using water and ethyl acetate, placing the protein solution in a magnetic stirring pot at 50 ℃, heating and keeping the temperature constant for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 90 minutes, and then heating at 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, the beta-carotene solution is dropwise added into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 6min, and the ratio of the final organic solution to the water solution is 1: 5. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifugal machine at the rotating speed of 10000r/min for 20 min.
Example 8
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 2% (w/w) of protein solution and 0.1% (w/w) of beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 60 minutes, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, the beta-carotene solution is dropwise added into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 6min, and the ratio of the final organic solution to the water solution is 1: 2. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifuge at the rotating speed of 10000r/min for 20 min.
Example 9
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 2% (w/w) of protein solution and 0.1% (w/w) of beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 60 minutes, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, the beta-carotene solution is dropwise added into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 6min, and the ratio of the final organic solution to the water solution is 1: 9. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifuge at the rotating speed of 10000r/min for 20 min.
Example 10
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 2% (w/w) of protein solution and 0.1% (w/w) of beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 60 minutes, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, the beta-carotene solution is dropwise added into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 4min, and the ratio of the final organic solution to the water solution is 1: 9. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifugal machine at the rotating speed of 10000r/min for 20 min.
Example 11
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 2% (w/w) of protein solution and 0.1% (w/w) of beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding flavourzyme (Sigma P6110) into the protein solution, reacting for 60 minutes, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, the beta-carotene solution is dropwise added into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 8min, and the ratio of the final organic solution to the water solution is 1: 9. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifuge at the rotating speed of 10000r/min for 20 min.
Comparative example 1
Accurately weighing soybean protein isolate and beta-carotene by using an analytical balance, preparing 2% (w/w) of protein solution and 0.1% (w/w) of beta-carotene solution by using water and ethyl acetate, placing the protein solution in a heat collection type constant temperature heating magnetic stirrer, heating at the rotating speed of 200r/min and the temperature of 50 ℃ and keeping the constant temperature for 10 minutes, adding alkaline protease (Novesson Alcalase 2.4L FG) into the protein solution, reacting for 60 minutes, and then heating at the temperature of 85 ℃ for 10 minutes to inactivate the enzyme. After cooling to room temperature, dropwise adding the beta-carrot solution into the enzyme-deactivated enzymolysis liquid under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding lutein into the granule with high speed stirrer at 8000rpm/min for 4min, and mixing the final organic solution and water at a ratio of 1: 5. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifuge at the rotating speed of 10000r/min for 20 min.
Comparative example 2
Accurately weighing the isolated soy protein and the beta-carotene by using an analytical balance, preparing 0.5% (w/w) protein solution by using water and ethyl acetate, and dropwise adding the beta-carotene solution into the isolated soy protein solution under the stirring condition of a high-speed stirrer at 8000 rpm/in. Embedding beta-carotene into the granules by using a high-speed stirrer, wherein the rotating speed is 8000rpm/min, the time is 4min, and the ratio of the final organic solution to the water solution is 1: 5. And removing ethyl acetate by using a nitrogen blowing instrument, and finally removing a small amount of insoluble substances by using a centrifugal machine at the rotating speed of 10000r/min for 20 min.
Example 12
Beta-carotene prepared in examples 1 to 11 and comparative examples 1 and 2 was used for detection, encapsulation efficiency thereof was measured and in vitro simulated digestion was performed.
The in vitro simulated digestion method is as follows:
5mL of the beta-carotene nanocarrier sample was mixed with an equal amount of ultrapure water, added to 10mL of simulated gastric fluid (containing 2g/L NaCl L, 3.2g/L pepsin, and 7mL/L concentrated HCl), and then the pH was adjusted to 2.0 with 0.5M NaOH or 0.5M HCl. The digest was stirred slowly at 37 ℃ for 1 hour. Immediately after the gastric phase digestion, the digested sample was adjusted to ph7.0 with 2.5M sodium hydroxide. Then 20mL of a simulated intestinal solution (containing 8mg/mL bile salts, 1mg/mL trypsin and 5mM calcium chloride, pH7.0 in PBS buffer) was added to the sample solution at a ratio of 1:1, and the reaction was carried out at 37 ℃ for 2 hours with slow stirring.
The encapsulation and bioavailability of the resulting digested digest β -carotene was determined and the results obtained are reported in table 1.
TABLE 1 encapsulation efficiency and bioavailability of beta-carotene prepared in examples 1-11 and comparative examples 1, 2
Examples | Encapsulation efficiency (%) | Biological availability (%) |
Example 1 | 62.1±0.23 | 66.1±0.32 |
Example 2 | 52.3±0.49 | 56.3±0.83 |
Example 3 | 39.9±0.65 | 45.1±0.54 |
Example 4 | 42.1±0.39 | 45.6±0.67 |
Example 5 | 52.1±0.42 | 57.1±0.92 |
Example 6 | 92.1±0.19 | 95.2±0.44 |
Example 7 | 82.1±0.39 | 85.2±0.56 |
Example 8 | 42.1±0.41 | 42.3±0.87 |
Example 9 | 82.1±0.98 | 86.1±0.76 |
Example 10 | 62.1±0.43 | 63.2±0.23 |
Example 11 | 72.1±0.78 | 78.1±0.98 |
Comparative example 1 | 32.1±0.49 | 33.1±0.93 |
Comparative example 2 | 10.12±0.32 | 13.3±0.42 |
As can be seen from table 1, the encapsulation efficiency and bioavailability of the β -carotene carrier prepared in example 6 were the highest, and the preferred example was example 6. Meanwhile, as can be seen from table 1, the encapsulation efficiency and the bioavailability of the examples are much higher than those of the comparative examples 1-2, which shows the superiority of the examples.
The highest encapsulation efficiency and bio-availability data were obtained for the beta-carotene carriers prepared in examples 1, 2, and 3, and the optimal concentration of the protein solution was 2% (w/w).
The best ratio of enzyme to protein was 0.1% (w/w), based on the highest encapsulation efficiency and bioavailability data obtained for the beta-carotene carriers prepared in examples 1, 4, 5.
The highest encapsulation efficiency and bioavailability data were obtained for the beta-carotene carriers prepared in examples 1, 6, and 7, and the optimal time for enzymatic hydrolysis was 60 min.
The highest maximum encapsulation efficiency and bioavailability data were obtained for the beta-carotene carriers prepared in examples 6, 8, and 9, and the optimal ratio condition for mixing the proteolytic enzymatic hydrolysate and the organic phase was 1: 5.
The highest encapsulation and bioavailability data were obtained for the beta-carotene carriers prepared in examples 6, 10, and 11, and the optimal time for high speed dispersion was 4 minutes.
Example 13
Secondary structures were measured by circular dichroism using the protein enzymatic hydrolysate and the protein solution prepared in example 6 and comparative examples 1 and 2, and the obtained results are recorded in table 2.
Table 2 secondary structure content of solutions prepared in example 6 and comparative examples 1 and 2
Two-stage structure | Alpha-helix | beta-S sheet | Beta-turn angle | Random crimp |
Example 6 | 22.60% | 46.10% | 16.30% | 15.60% |
Comparative example 1 | 17.00% | 52.50% | 14.50% | 14.20% |
Comparative example 2 | 13.40% | 52.30% | 21.10% | 13.20% |
As can be seen from table 2, the content of α -helix and random coil in example 6 is higher than that in comparative example 1 and comparative example 2, which indicates that the particles formed in comparative example 6 are more flexible and flexible in structure, which helps protein molecules to be closely adsorbed on the interface, so that the nanoparticles have better emulsibility, and the β -carotene is more easily encapsulated by the nanoparticles.
Example 14
The free amino acid content was determined using the solutions prepared in example 6 and comparative example 1 and compared to the SPI total amino acid content, and the results obtained are reported in table 3.
TABLE 3 content of free amino acids and amount of SPI total amino acids in the finally prepared solutions of EXAMPLE 6 and COMPARATIVE EXAMPLE 1
As can be seen from Table 3, the percentage difference between the release of free amino acids in example 6 and that in comparative example 1 was large, and the release of met (20.33%), phe (16.16%), leu (13.12%) was relatively large for each amino acid in example 6. Comparative example 1, however, contained a greater amount of free amino acids-cys-s (23.66%) and val (15.2%), leu (37, 97%), phe (19.65%) with the remaining amino acids not much exposed.
This is because natural soy protein isolate is a globular protein, usually located internally with most non-polar amino acids and polar amino acids on the outside. The polypeptide chains fold into a compact, globular conformation. These subunits in turn associate with each other to form a complex quaternary structure. The soybean protein molecules are highly compressed and have compact structures, so that hydrophobic active substances are difficult to wrap in the soybean protein molecules, and the controlled release performance of the soybean protein molecules on loaded fat-soluble functional ingredients is poor.
The alkaline protease hydrolyzes peptide bonds of hydrophobic amino acids, which are peptide bonds in the protein, and meanwhile, the hydrolysis specificity is low, and the peptide bonds of certain specific amino acids cannot be hydrolyzed, so that more hydrophobic amino acids are liberated, the hydrophobic amino acids in the particles are fewer, the contact positions of the particles and beta-carotene are reduced, and the encapsulation efficiency is lower.
The flavourzyme is characterized in that the endoprotease and the exoenzyme can hydrolyze peptide bonds on peptide chains, so that some hydrophilic amino acids on the surfaces and hydrophobic amino acids in the interior can be hydrolyzed in the process of preparing the nano particles, the interior with a compact structure hidden in the interior is exposed, the formed particles are more amphiphilic, and therefore beta-carotene can be embedded in the interior of the particles more easily, and the flavourzyme used in the embodiment has certain superiority in effect compared with alkaline protease.
Example 15
The nanoparticles of example 6 and comparative example 1 were photographed by transmission electron microscopy and subjected to in vitro simulated digestion, wherein gastric digestion was performed for 0, 5, 15, 30, and 60 minutes, intestinal digestion was performed for 0, 5, 15, 30, 60, and 90120 minutes, and the release rate of beta-carotene was measured, as shown in fig. 2, the release rate of beta-carotene was significantly lower in gastric digestion than in comparative example 1, demonstrating that the nanoparticles formed in example 6 have a certain resistance to digestion. As shown in fig. 2, the nanoparticles prepared in example 6 have a lower release rate of β -carotene than comparative example 1 during intestinal digestion, and achieve the desired sustained release effect.
It should be noted that the above-mentioned embodiments are only for illustrating the technical solutions of the present invention and not for limiting, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions may be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, which should be covered by the claims of the present invention.
Claims (10)
1. A preparation method of flavor enzyme enzymolysis nanoparticles for resisting gastrointestinal digestion is characterized by comprising the following steps: the method comprises the following steps:
preparing particles, namely performing enzymolysis on a protein solution by using flavor enzyme, heating to inactivate the enzyme and simultaneously promoting self-assembly to prepare nano particles;
preparing an organic phase, namely mixing the fat-soluble nutrient with an organic solvent to prepare a fat-soluble nutrient solution;
mixing the two phases: mixing the fat-soluble nutrient solution and the nano particles by using a high-speed stirrer;
removing an organic phase: removing the organic solvent by using a nitrogen blowing instrument;
removing a small amount of insoluble substances, centrifuging the hydrolysate at a rotation speed of 10000r/min for 20 min.
2. The method for preparing flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion according to claim 1, wherein the method comprises the following steps: in the preparation organic phase, the organic solvent comprises one or more of dichloromethane, methanol, ethyl acetate, trichloromethane and acetonitrile.
3. The method for preparing flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion according to claim 1, wherein the method comprises the following steps: in the prepared particles, the protein in the protein solution is one or more of soybean protein isolate, alpha-lactalbumin, rice protein, peanut protein isolate, bovine serum albumin, casein and zein.
4. The method for preparing flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion according to claim 1, wherein the method comprises the following steps: in the organic phase, the fat-soluble nutrient comprises one of beta-carotene, vitamin-E, lutein, curcumin, resveratrol and vitamin D.
5. The method for preparing flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion according to claim 2, wherein the method comprises the following steps: in the two-phase mixing, the fat-soluble nutrient solution and the nano particles are mixed according to the volume ratio of 1: 2-9.
6. The method for preparing flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion according to claim 3, wherein the method comprises the following steps: in the prepared particles, the concentration of the protein solution is 0.5-2% by weight.
7. The method for preparing flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion according to claim 1, wherein the method comprises the following steps: in the prepared particles, the ratio of the flavor enzyme to the substrate is 0.05-0.2% by weight.
8. The method for preparing flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion according to claim 1, wherein the method comprises the following steps: in the two-phase mixing, the rotating speed of a high-speed stirrer is 8000rpm, and the stirring time is 4-8 min.
9. The method for preparing flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion according to claim 6, wherein the method comprises the following steps: in the preparation of granules, the concentration of the protein solution was 2% by weight.
10. The method for preparing flavourzyme enzymolysis nanoparticles for resisting gastrointestinal digestion according to claim 7, wherein the method comprises the following steps: in the prepared granules, the ratio of flavourzyme to substrate was 0.1% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210380054.XA CN114617262A (en) | 2022-04-07 | 2022-04-07 | Preparation method of flavor enzyme enzymolysis nanoparticles for resisting gastrointestinal digestion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210380054.XA CN114617262A (en) | 2022-04-07 | 2022-04-07 | Preparation method of flavor enzyme enzymolysis nanoparticles for resisting gastrointestinal digestion |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114617262A true CN114617262A (en) | 2022-06-14 |
Family
ID=81906502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210380054.XA Pending CN114617262A (en) | 2022-04-07 | 2022-04-07 | Preparation method of flavor enzyme enzymolysis nanoparticles for resisting gastrointestinal digestion |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114617262A (en) |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488186A (en) * | 2011-12-06 | 2012-06-13 | 江南大学 | Edible nano-scale beta-carotene emulsion free from high pressure homogenization and preparation method thereof |
CN105054073A (en) * | 2015-08-10 | 2015-11-18 | 华南理工大学 | Water-soluble vitamin D3 nanometer particles and preparation method thereof |
CN106858587A (en) * | 2017-01-18 | 2017-06-20 | 华南理工大学 | Soybean protein isolate curcumin nano particle conjugate and preparation method thereof |
CN108157585A (en) * | 2018-01-05 | 2018-06-15 | 华南理工大学 | A kind of soybean protein base nano particle for loading resveratrol and its preparation method and purposes |
CN108208834A (en) * | 2018-01-05 | 2018-06-29 | 华南理工大学 | A kind of soybean protein base nano particle for loading curcumin and its preparation method and purposes |
CN109511772A (en) * | 2018-11-26 | 2019-03-26 | 华南理工大学 | A kind of dissolution, synergy indissoluble bioactive substance albumen base nano particle preparation method |
CN110129395A (en) * | 2019-04-17 | 2019-08-16 | 华南理工大学 | A kind of activated protein nano particle and the preparation method and application thereof of limited enzymatic hydrolysis preparation |
CN110897161A (en) * | 2019-11-22 | 2020-03-24 | 华南理工大学 | Soybean polypeptide-based nanoparticle with high load of curcumin, and pH-driven preparation method and application thereof |
CN112772923A (en) * | 2021-02-02 | 2021-05-11 | 山东农业大学 | Soybean peptide aggregate-based beta-carotene embedding emulsion and preparation method thereof |
CN112790384A (en) * | 2021-01-14 | 2021-05-14 | 江南大学 | Preparation method of gel-coated beta-carotene nanoparticles |
CN113796533A (en) * | 2021-08-26 | 2021-12-17 | 华南理工大学 | Pickering nano emulsion with stable soybean protein particles and loaded lutein ester and preparation method thereof |
-
2022
- 2022-04-07 CN CN202210380054.XA patent/CN114617262A/en active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488186A (en) * | 2011-12-06 | 2012-06-13 | 江南大学 | Edible nano-scale beta-carotene emulsion free from high pressure homogenization and preparation method thereof |
CN105054073A (en) * | 2015-08-10 | 2015-11-18 | 华南理工大学 | Water-soluble vitamin D3 nanometer particles and preparation method thereof |
CN106858587A (en) * | 2017-01-18 | 2017-06-20 | 华南理工大学 | Soybean protein isolate curcumin nano particle conjugate and preparation method thereof |
CN108157585A (en) * | 2018-01-05 | 2018-06-15 | 华南理工大学 | A kind of soybean protein base nano particle for loading resveratrol and its preparation method and purposes |
CN108208834A (en) * | 2018-01-05 | 2018-06-29 | 华南理工大学 | A kind of soybean protein base nano particle for loading curcumin and its preparation method and purposes |
CN109511772A (en) * | 2018-11-26 | 2019-03-26 | 华南理工大学 | A kind of dissolution, synergy indissoluble bioactive substance albumen base nano particle preparation method |
CN110129395A (en) * | 2019-04-17 | 2019-08-16 | 华南理工大学 | A kind of activated protein nano particle and the preparation method and application thereof of limited enzymatic hydrolysis preparation |
CN110897161A (en) * | 2019-11-22 | 2020-03-24 | 华南理工大学 | Soybean polypeptide-based nanoparticle with high load of curcumin, and pH-driven preparation method and application thereof |
CN112790384A (en) * | 2021-01-14 | 2021-05-14 | 江南大学 | Preparation method of gel-coated beta-carotene nanoparticles |
CN112772923A (en) * | 2021-02-02 | 2021-05-11 | 山东农业大学 | Soybean peptide aggregate-based beta-carotene embedding emulsion and preparation method thereof |
CN113796533A (en) * | 2021-08-26 | 2021-12-17 | 华南理工大学 | Pickering nano emulsion with stable soybean protein particles and loaded lutein ester and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110897161B (en) | Soybean polypeptide-based nanoparticle with high load of curcumin, and pH-driven preparation method and application thereof | |
Liu et al. | Preparation, characterization, and antioxidant activity of zein nanoparticles stabilized by whey protein nanofibrils | |
Tang | Assembly of food proteins for nano-encapsulation and delivery of nutraceuticals (a mini-review) | |
Ren et al. | Encapsulation of curcumin in ZEIN-HTCC complexes: Physicochemical characterization, in vitro sustained release behavior and encapsulation mechanism | |
He et al. | Ultrasonication promotes extraction of antioxidant peptides from oxhide gelatin by modifying collagen molecule structure | |
CN110089753A (en) | A kind of preparation method for the nanoparticle improving curcumin bioavailability | |
CN112273654A (en) | Method for preparing soybean protein enzymolysis aggregate embedded curcumin nanoparticles by pH driving method and application thereof | |
CN108208834B (en) | Curcumin-loaded soybean protein-based nanoparticles and preparation method and application thereof | |
CN109511772B (en) | Preparation method of protein-based nanoparticles of dissolution-promoting and synergistic insoluble bioactive substances | |
Zhang et al. | Stability and in vitro digestion simulation of soy protein isolate-vitamin D3 nanocomposites | |
Jing et al. | Self-coacervation of carboxymethyl chitosan as a pH-responsive encapsulation and delivery strategy | |
CN110574931A (en) | microencapsulated low-bitter functional soybean polypeptide and preparation method and application thereof | |
CN112956680A (en) | Plant oil body-imitated core-shell liposome and preparation method thereof | |
CN108157585B (en) | Resveratrol-loaded soybean protein-based nano-particles and preparation method and application thereof | |
CN114403446B (en) | High-stability high-concentration turmeric extract aqueous solution and preparation method and application thereof | |
Mala et al. | Protection and controlled gastrointestinal release of bromelain by encapsulating in pectin–resistant starch based hydrogel beads | |
Lv et al. | Improvement of the encapsulation capacity and emulsifying properties of soy protein isolate through controlled enzymatic hydrolysis | |
CN107252132B (en) | Casein-carragheen independently fills the preparation method and applications of capsule of nano | |
Shi et al. | Formation mechanism and stability of low environment-sensitive ternary nanoparticles based on zein-pea protein-pectin for astaxanthin delivery | |
CN114617262A (en) | Preparation method of flavor enzyme enzymolysis nanoparticles for resisting gastrointestinal digestion | |
CN108246214B (en) | Method for preparing polypeptide microcapsule by one-step adsorption method | |
Gong et al. | Preparation of soybean protein-based nanoparticles and its application as encapsulation carriers of bioactive substances | |
Lu et al. | Subcritical water‐treated soy protein‐gum Arabic core‐shell nanoparticles as phytosterol carriers | |
CN110498932B (en) | Casein-pectin-protocatechuic acid ternary complex, and preparation method and application thereof | |
CN114159409A (en) | Preparation method of glycosylated zein polypeptide carried lutein nanoparticles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220614 |